cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Verrica Pharmaceuticals Inc
2 own
5 watching
Current Price
$6.34
$0.62
(10.84%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
260.54M
52-Week High
52-Week High
9.22
52-Week Low
52-Week Low
1.77
Average Volume
Average Volume
0.51M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization260.54M
icon52-Week High9.22
icon52-Week Low1.77
iconAverage Volume0.51M
iconDividend Yield--
iconP/E Ratio--
What does the Verrica Pharmaceuticals Inc do?
Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company s lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and which is in Phase II clinical trial for treating common warts. It is also developing cantharidin-based product candidate, VP-103 for treating plantar warts. The company has a license and collaboration agreement with Torii Pharmaceutical Co., Ltd. for the development and commercialization of its product candidates for the treatment of molluscum contagiosum and common warts in Japan, including VP-102; and a license agreement with Lytix Biopharma AS to develop and commercialize LTX-315 for dermatological oncology indications. Verrica Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in West Chester, Pennsylvania.
Read More
How much money does Verrica Pharmaceuticals Inc make?
News & Events about Verrica Pharmaceuticals Inc.
Globe Newswire
1month ago
Registration Stability Batch for VP-102 Completed and Placed on Stability Process Validation Batches Successfully Manufactured Verrica Reaffirms its Expected Q1 2023 NDA Resubmission for VP-102 WEST CHESTER, Pa., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (Verrica) (Nasdaq: VRCA...
Ticker Report
2 months ago
Verrica Pharmaceuticals (NASDAQ:VRCA Get Rating) and Lexicon Pharmaceuticals (NASDAQ:LXRX Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, risk, ...
Zolmax
2 months ago
Verrica Pharmaceuticals (NASDAQ:VRCA Get Rating) and Lexicon Pharmaceuticals (NASDAQ:LXRX Get Rating) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, dividends, ...
PR Newswire
6 months ago
VRCA SHAREHOLDER ALERT: Jakubowitz Law Reminds Verrica Shareholders of a Lead Plaintiff Deadline of August 5, 2022 VRCA SHAREHOLDER ALERT: Jakubowitz Law Reminds Verrica Shareholders of a Lead Plaintiff Deadline of August 5, 2022 PR Newswire NEW YORK, Aug. 5, 2022 NEW YORK, Aug. 5, 2022...
PR Newswire
6 months ago
FINAL DEADLINE ALERT: The Schall Law Firm Encourages Investors in Verrica Pharmaceuticals Inc. with Losses of $100,000 to Contact the Firm FINAL DEADLINE ALERT: The Schall Law Firm Encourages Investors in Verrica Pharmaceuticals Inc. with Losses of $100,000 to Contact the Firm PR Newswire LOS...
Frequently Asked Questions
Frequently Asked Questions
What is Verrica Pharmaceuticals Inc share price today?
plus_minus_icon
Can Indians buy Verrica Pharmaceuticals Inc shares?
plus_minus_icon
How can I buy Verrica Pharmaceuticals Inc shares from India?
plus_minus_icon
Can Fractional shares of Verrica Pharmaceuticals Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Verrica Pharmaceuticals Inc stocks?
plus_minus_icon
What is today’s traded volume of Verrica Pharmaceuticals Inc?
plus_minus_icon
What is today’s market capitalisation of Verrica Pharmaceuticals Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Verrica Pharmaceuticals Inc?
plus_minus_icon
What percentage is Verrica Pharmaceuticals Inc down from its 52-Week High?
plus_minus_icon
What percentage is Verrica Pharmaceuticals Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$6.34
$0.62
(10.84%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00